Cardiovascular diseases are a leading cause of global mortality, with increased risk for women after menopause. Identifying accessible biomarkers for assessing subclinical risk is a key clinical priority. The uric acid to HDL-cholesterol ratio (UHR) is a composite marker reflecting metabolic burden and reduced vascular protection.
Study Design and Population
This study examined the association between UHR and subclinical organ damage, investigating sex-specific differences. The analysis included 1,198 Caucasian subjects. Subclinical cardiovascular damage was evaluated using carotid intima-media thickness (c-IMT) and left ventricular mass index (LVMI).
Key Clinical Findings
UHR correlated significantly with adiposity, insulin resistance, blood pressure, and lipid profiles. In the total population, UHR was independently associated with both c-IMT and LVMI. A significant sex-UHR interaction was observed for LVMI. Sex-stratified analyses revealed that UHR was linked to LVMI in women, particularly those postmenopausal, but not in males. In postmenopausal women, UHR remained an independent determinant of LVMI. **UHR** was a significant factor in assessing cardiovascular risk.